Advertisement

Peptides in Major Psychoses

  • Ole J. Rafaelsen

Abstract

During the last decades, biological interest in depression has focused on neuroendocrinological disturbances. Accordingly the involvement of minor peptide hormones present in the brain have been hypothesized and studied. Thus an impaired thyrotropin (TSH) response to thyrotropin releasing hormone (TRH) has been described (Prange et al., 1972; Kastin et al., 1972), and furthermore Kirkegaard et al. (1975) and Kirkegaard and Smith (1978) showed that changes in TSH response to TRH during electroconvulsive therapy (ECT) seem to be of predictive value for the post-treatment course of the disease. Moreover, Kirkegaard et al. (1979), reported high levels of TRH in cerebrospinal fluid (CSF) in endogenous depression.

Keywords

Growth Hormone Schizophrenic Patient Vasoactive Intestinal Polypeptide Thyrotropin Release Hormone Electroconvulsive Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Checkley, S.A., and Crammer, J.L., 1977, Hormone responses to methylamphetamine in depression: A new approach to the noradrenaline depletion hypothesis, Br J Psychiatry, 131:582.PubMedCrossRefGoogle Scholar
  2. Checkley, S.A., Slade, A.P., and Shur, E., 1981, Growth hormone and other responses to clonidine in patients with endogenous depression, Br J Psychiatry, 138:51.PubMedCrossRefGoogle Scholar
  3. De Wied, D., 1977, Peptides and behavior, Life Sci, 20:195.PubMedCrossRefGoogle Scholar
  4. Fahrenkrug, J., 1979, Vasoactive intestinal polypeptide: measurement, distribution and putative neurotransmitter function, Digestion, 19:149.PubMedCrossRefGoogle Scholar
  5. Gerner, R.H., and Yamada, T., 1982, Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients, Brain Res, 238:298.PubMedCrossRefGoogle Scholar
  6. Gjerris, A., Fahrenkrug, J., Bojholm, S., and Rafaelsen, O. J., 1981, Vasoactive Intestinal Polypeptide (VIP) in cerebrospinal fluid in psychiatric disorders, in: “Biological Psychiatry”, C. Perris, G. Struwe, and B. Jansson, eds., Elsevier/Borth-Holland Biomedical Press, Amsterdam, 565.Google Scholar
  7. Gjerris, A., Rafaelsen, O.J., Vendsborg, P., and Rehfeld, J.,1983,Gastrointestinal peptides in cerebrospinal fluid in psychiatric disorders, J Affective Pis, to be published.Google Scholar
  8. Gold, P.W. and Goodwin, F.K., 1978, Vasopressin in affective illness, Lancet, i:1233.CrossRefGoogle Scholar
  9. Hokfelt, T., Johansson, O., Ljungdahl, A., Lundberg, J.M., and Schultzberg, M., 1980a, Peptidergic neurones, Nature, 284:515.PubMedCrossRefGoogle Scholar
  10. Hokfelt, T., Rehfeld, J.F., Skirboll, L., Ivemark, B., Goldstein, M., and Markey, K., 1980b, Evidence for coexistence of dopamine and CCK in meso-limbic neurones, Nature, 285:476.PubMedCrossRefGoogle Scholar
  11. Itoh, H., Tanoue, S., Yagi, G., Tateyama, M., Kamisada, M., Fujii, Y., Takamiya, M., and Nakajima, S., 1982, Clinical study on the psychotropic effects of caerulein — an open clinical trial in. chronic schizophrenic patients, Keio J Med, 31:71.PubMedCrossRefGoogle Scholar
  12. Johansson, B.B., Fahrenkrug, J., Wikkelso, C., Andersen, O., and Blomstrand, C., 1982, Vasoactive intestinal polypeptide in human cerebrospinal fluid, Front Horm Res, 9:189.Google Scholar
  13. Kastin, A.J., Ehrensing, R.H., Schalch, D.S., and Anderson, M.S., 1972, Improvement in mental depression with decreased thyrotropin response after administration of thyrotropinreleasing hormone, Lancet, ii:740.CrossRefGoogle Scholar
  14. Kirkegaard, C., Norlem, N., Lauridsen, U.B., and Bjorum, N., 1975, Prognostic value of thyrotropinreleasing hormone stimulation test in endogenous depression, Acta Psychiatr Scand, 52:170.PubMedCrossRefGoogle Scholar
  15. Kirkegaard, C. and Smith, E., 1978, Continuation therapy in endogenous depression controlled by changes in the TRH stimulation test, Psychol Med, 8:501.PubMedCrossRefGoogle Scholar
  16. Kirkegaard, C., Faber, J., Hummer, L., and Rogowski, P., 1979, Increased levels of TRH in cerebrospinal fluid from patients with endogenous depression, Psychoneuroendocrinology, 4:227.PubMedCrossRefGoogle Scholar
  17. Koob, G.E. and Bloom, F.E., 1982, Behavioral effects of neuropeptides: Endorphins and vasopressin, Annu Rev Physiol, 44:571.PubMedCrossRefGoogle Scholar
  18. Laakmann, G., 1980, Effect of antidepressants on the secretion of pituitary hormones in healthy subjects, neurotic depressive patients and endogenous depressive patients, Nervenarzt, 51:725.PubMedGoogle Scholar
  19. Maroji, T., Watanabee, N., Aoki, N., and Itoh, S., 1982, Antipsychotic effects of ceruletide (caerulein) on chronic schizophrenia, Arch Gen Psychiatry, 39:485.CrossRefGoogle Scholar
  20. Matussek, N., Ackenheil, M., Hippius, H., Müller, F., Schroder, H.-Th., Schultes, H., and Wasilewski, B., 1980, Effect of Clonidine on growth hormone release in psychiatric patients and controls. Psychiatry Res, 2:25.PubMedCrossRefGoogle Scholar
  21. Prange, Jr., A.J., Lara, P.P., Wilson, I.C., Alltop, L.B., and Breese, G.R., 1972, Effects of thyrotropinreleasing hormone in depression, Lancet, ii:999.CrossRefGoogle Scholar
  22. Rafaelsen, O.J., 1980, Biology of manic-melancholic disorders, Med J Aust, 1:637.PubMedGoogle Scholar
  23. Rehfeld, J.F., 1978, Immunochemical studies on cholecystokinin. II. Distribution and molecular heterogeneity in the central nervous system and small intestine, J Biol Chem, 253:4022.PubMedGoogle Scholar
  24. Sachar EJ, Altman, N. Gruen, P.H., Glassman, A., Halpern, F.S., and Sassin, J., 1975, Human growth hormone response to levodopa, Arch Gen Psychiatry, 32:502.PubMedCrossRefGoogle Scholar
  25. Sachar, E.J., Finkelstein, J., and Hellmann, L., 1971, Growth hormone responses in depressive illness. I. Response to insulin tolerance test, Arch Gen Psychiatry, 25:263.CrossRefGoogle Scholar
  26. Weingartner, H., Gold, P., Ballenger, J.C., Smallberg, S.A., Summers, R., Rubinow, D.R., Post, R.M., and Goodwin, F.K., 1981, Effects of vasopressin on human memory functions, Science 211:601.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1985

Authors and Affiliations

  • Ole J. Rafaelsen
    • 1
  1. 1.Psychochemistry Institute & Department of Psychiatry RigshospitaletCopenhagenDenmark

Personalised recommendations